Tiziana Life Sciences Ltd TLSA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.19M | -6.19M | -6.40M | -6.40M | -2.82M |
| Total Depreciation and Amortization | 79.00K | 79.00K | 73.00K | 73.00K | 44.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.27M | 1.27M | 935.50K | 935.50K | 208.50K |
| Change in Net Operating Assets | 1.16M | 1.16M | 2.38M | 2.38M | -848.00K |
| Cash from Operations | -3.68M | -3.68M | -3.01M | -3.01M | -3.41M |
| Capital Expenditure | -30.00K | -30.00K | -7.50K | -7.50K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 89.00K | 89.00K | 1.44M |
| Cash from Investing | -30.00K | -30.00K | 81.50K | 81.50K | 1.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -65.00K | -65.00K | -74.00K | -74.00K | -24.00K |
| Issuance of Common Stock | 3.32M | 3.32M | 1.37M | 1.37M | 3.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 24.00K | 24.00K | -- |
| Cash from Financing | 3.26M | 3.26M | 1.32M | 1.32M | 3.68M |
| Foreign Exchange rate Adjustments | 36.50K | 36.50K | -13.00K | -13.00K | 55.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -416.00K | -416.00K | -1.62M | -1.62M | 1.76M |